Related references
Note: Only part of the references are listed.Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond
Matej Vizovisek et al.
MATRIX BIOLOGY (2019)
Cell penetrable, clickable and tagless activity-based probe of human cathepsin L
Dibyendu Dana et al.
BIOORGANIC CHEMISTRY (2019)
Cysteine Cathepsins in Tumor-Associated Immune Cells
Tanja Jakos et al.
FRONTIERS IN IMMUNOLOGY (2019)
Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain
Paul D. Boudreau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis
Julie A. Stone et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
Optimization of a Protease Activated Probe for Optical Surgical Navigation
Joshua J. Yim et al.
MOLECULAR PHARMACEUTICS (2018)
Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors
Maude Giroud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes
Marcin Poreba et al.
CHEMICAL SCIENCE (2018)
Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery
Carlos H. F. Chan et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors
Bernd Kuhn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Toolbox of Fluorescent Probes for Parallel Imaging Reveals Uneven Location of Serine Proteases in Neutrophils
Paulina Kasperkiewicz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy
Siddharth Mehra et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
The Future of Cysteine Cathepsins in Disease Management
Lovro Kramer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models
Mansi Manchanda et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L
Erica N. Parker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Inhibition of the Cysteine Protease Human Cathepsin L by Triazine Nitriles: Amide...Heteroarene π-Stacking Interactions and Chalcogen Bonding in the S3 Pocket
Maude Giroud et al.
CHEMMEDCHEM (2017)
The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease
Pasquale Cocchiaro et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94
Dhivya R. Sudhan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Caught in the act: the crystal structure of cleaved cathepsin L bound to the active site of Cathepsin L
Piotr Sosnowski et al.
FEBS LETTERS (2016)
Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins
Stjepko Cermak et al.
PLOS ONE (2016)
Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L
Pierre-Marie Andrault et al.
BIOCHEMISTRY (2015)
Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L
Erica N. Parker et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
THE CATHEPSIN-L INHIBITOR CAA0225 PROTECTS AGAINST MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY
W. He et al.
HEART (2015)
Multiple Cathepsins Promote Pro-IL-1β Synthesis and NLRP3-Mediated IL-1β Activation
Gregory M. Orlowski et al.
JOURNAL OF IMMUNOLOGY (2015)
Cathepsin L targeting in cancer treatment
Dhivya R. Sudhan et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis
Euan Ramsay Orr Allan et al.
PLOS ONE (2015)
Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes
Reik Loeser et al.
FRONTIERS IN CHEMISTRY (2015)
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
Marton Siklos et al.
ACTA PHARMACEUTICA SINICA B (2015)
Cathepsin Inhibition-Induced Lysosomal Dysfunction Enhances Pancreatic Beta-Cell Apoptosis in High Glucose
Minjeong Jung et al.
PLOS ONE (2015)
An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis
Yoko Hashimoto et al.
PLOS ONE (2015)
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Oakley C. Olson et al.
NATURE REVIEWS CANCER (2015)
Activity-Based Profiling of Proteases
Laura E. Sanman et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Development of a highly potent, selective, and cell-active Inhibitor of cysteine cathepsin L-A hybrid design approach
Dibyendu Dana et al.
CHEMICAL COMMUNICATIONS (2014)
Prodrug-Inspired Probes Selective to Cathepsin B over Other Cysteine Cathepsins
Morshed A. Chowdhury et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Marine Cyanobacterial Metabolite Gallinamide A Is a Potent and Selective Inhibitor of Human Cathepsin L
Bailey Miller et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Podocyte Biology and Pathogenesis of Kidney Disease
Jochen Reiser et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: A randomized population-based study
Bing-Jie Lv et al.
ATHEROSCLEROSIS (2013)
Identification of new peptide amides as selective cathepsin L inhibitors: The first step towards selective irreversible inhibitors?
Ana Torkar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Optimization of Triazine Nitriles as Rhodesain Inhibitors: StructureActivity Relationships, Bioisosteric Imidazopyridine Nitriles, and X-ray Crystal Structure Analysis with Human CathepsinL
Veronika Ehmke et al.
CHEMMEDCHEM (2013)
Biogenesis and Proteolytic Processing of Lysosomal DNase II
Susumu Ohkouchi et al.
PLOS ONE (2013)
Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease
Nobuhide Ueki et al.
NATURE COMMUNICATIONS (2013)
Cysteine cathepsins: From structure, function and regulation to new frontiers
Vito Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
A Novel Photoaffinity-Based Probe for Selective Detection of Cathepsin L Active Form
Ana Torkar et al.
CHEMBIOCHEM (2012)
Microarray-guided discovery of two-photon (2P) small molecule probes for live-cell imaging of cysteinyl cathepsin activities
Zhenkun Na et al.
CHEMICAL COMMUNICATIONS (2012)
Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment
Uta Schurigt et al.
INFLAMMATION RESEARCH (2012)
The Tick Salivary Protein Sialostatin L Inhibits the Th9-Derived Production of the Asthma-Promoting Cytokine IL-9 and Is Effective in the Prevention of Experimental Asthma
Helena Horka et al.
JOURNAL OF IMMUNOLOGY (2012)
Protease-Activated Drug Development
Ki Young Choi et al.
THERANOSTICS (2012)
Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions
Leo A. Hardegger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Homing of Progenitor Cells to Ischemic Tissues
Emmanouil Chavakis et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Azepanone-based inhibitors of human cathepsin S: Optimization of selectivity via the P2 substituent
Jeffrey K. Kerns et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Cathepsin-L contributes to cardiac repair and remodelling post-infarction
Mei Sun et al.
CARDIOVASCULAR RESEARCH (2011)
Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments
Leo A. Hardegger et al.
CHEMMEDCHEM (2011)
Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes
Laura E. Edgington et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors
Rajesh T. Shenoy et al.
JOURNAL OF STRUCTURAL BIOLOGY (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Parkinson's disease involves autophagy and abnormal distribution of cathepsin L
Lingyun Li et al.
NEUROSCIENCE LETTERS (2011)
Structural basis for the recognition and cleavage of histone H3 by cathepsin L
Melanie A. Adams-Cioaba et al.
NATURE COMMUNICATIONS (2011)
Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors
G. D. Kishore Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L
G. D. Kishore Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Real-time monitoring of drug release
Roy Weinstain et al.
CHEMICAL COMMUNICATIONS (2010)
Novel Peptidyl Aryl Vinyl Sulfones as Highly Potent and Selective Inhibitors of Cathepsins L and B
Laura Mendieta et al.
CHEMMEDCHEM (2010)
Enhancing the Outcome of Cell Therapy for Cardiac Repair Progress From Bench to Bedside and Back
Emmanouil Chavakis et al.
CIRCULATION (2010)
Strategies for discovering and derisking covalent, irreversible enzyme inhibitors
Douglas S. Johnson et al.
FUTURE MEDICINAL CHEMISTRY (2010)
Cathepsin L Inactivates Human Trypsinogen, Whereas Cathepsin L-Deletion Reduces the Severity of Pancreatitis in Mice
Thomas Wartmann et al.
GASTROENTEROLOGY (2010)
Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse
Lianne C. Hsing et al.
JOURNAL OF AUTOIMMUNITY (2010)
Specialized roles for cysteine cathepsins in health and disease
Jochen Reiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cells
Parag P. Shah et al.
MOLECULAR PHARMACOLOGY (2010)
Cathepsin L, target in cancer treatment?
Jacqueline M. Lankelma et al.
LIFE SCIENCES (2010)
Finding enzymes that are actively involved in cancer
Matthew Bogyo
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The proteome of lysosomes
Bernd A. Schroeder et al.
PROTEOMICS (2010)
A cathepsin L-specific inhibitor preferentially inhibits degradation of autophagosomal LC3 and GABARAP in HeLa and Huh-7 cells
Takashi Ueno et al.
AUTOPHAGY (2009)
Dipeptidyl nitrile inhibitors of Cathepsin L
Nabil Asaad et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Regulation of cell proliferation and differentiation in the kidney
Neal I. Alcalay et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Acquisition of T Regulatory Function in Cathepsin L-Inhibited T Cells by Eye-Derived CTLA-2α during Inflammatory Conditions
Sunao Sugita et al.
JOURNAL OF IMMUNOLOGY (2009)
A Combined Crystallographic and Molecular Dynamics Study of Cathepsin L Retrobinding Inhibitors
Rajesh T. Shenoy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3β signaling
Qizhu Tang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Activity-based protein profiling: From enzyme chemistry
Benjamin F. Cravatt et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Cathepsin L expression is up-regulated by hypoxia in human melanoma cells:: role of its 5′-untranslated region
Didier Jean et al.
BIOCHEMICAL JOURNAL (2008)
Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype
Michael C. Myers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Jacques Yves Gauthier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB
Jeremy P. Mallari et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor
Michael C. Myers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Crystal structure and silica condensing activities of silicatein α-cathepsin L chimeras
Michael Fairhead et al.
CHEMICAL COMMUNICATIONS (2008)
Molecular docking of cathepsin L inhibitors in the binding site of papain
Mary Pat Beavers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Exploring inhibitor binding at the S′ subsites of cathepsin L
Shafinaz F. Chowdhury et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells
Carmen Urbich et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Homing and engraftment of progenitor cells: A prerequisite for cell therapy
Emmanouil Chavakis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L
Parag P. Shah et al.
MOLECULAR PHARMACOLOGY (2008)
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
Christian Faul et al.
NATURE MEDICINE (2008)
Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1
Neal I. Alcalay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Cell type-specific functions of the lysosomal protease cathepsin L in the heart
Daniel Spira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes
Galia Blum et al.
NATURE CHEMICAL BIOLOGY (2007)
Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation
Brigitte Goulet et al.
MOLECULAR CANCER RESEARCH (2007)
Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease
Anna Ljunggren et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease
Sanja Sever et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice
Shiro Kitamoto et al.
CIRCULATION (2007)
Cysteine Cathepsins and the cutting edge of cancer invasion
Vasilena Gocheva et al.
CELL CYCLE (2007)
Aziridide-based inhibitors of cathepsin L: Synthesis, inhibition activity, and docking studies
Radim Vicik et al.
CHEMMEDCHEM (2006)
Cysteine cathepsins: multifunctional enzymes in cancer
Mona Mostafa Mohamed et al.
NATURE REVIEWS CANCER (2006)
Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick Ixodes scapularis
Michalis Kotsyfakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: Differences between calvaria and long bone
Vincent Everts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Global analysis of protein tyrosine phosphatase activity with ultra-sensitive fluorescent probes
Sanjai Kumar et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice
Ivonne Petermann et al.
FASEB JOURNAL (2006)
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities
Y Choe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
V Gocheva et al.
GENES & DEVELOPMENT (2006)
Rational design of aziridine-containing cysteine protease inhibitors with improved potency: Studies on inhibition mechanism
Radim Vicik et al.
CHEMMEDCHEM (2006)
Zebrafish KLF4 is essential for anterior mesendoderm/pre-polster differentiation and hatching
MR Gardiner et al.
DEVELOPMENTAL DYNAMICS (2005)
Azepanone-based inhibitors of human cathepsin L
RW Marquis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cathepsin L is essential for onset of autoimmune diabetes in NOD mice
R Maehr et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Dynamic imaging of protease activity with fluorescently quenched activity-based probes
G Blum et al.
NATURE CHEMICAL BIOLOGY (2005)
Activity-based probes that target diverse cysteine protease families
D Kato et al.
NATURE CHEMICAL BIOLOGY (2005)
Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate
C Gelhaus et al.
BIOLOGICAL CHEMISTRY (2004)
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor
B Goulet et al.
MOLECULAR CELL (2004)
Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy
W Potts et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2004)
Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection
K Onishi et al.
MICROBES AND INFECTION (2004)
Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and α3 integrin
J Reiser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Multiple roles for cysteine cathepsins in cancer
JA Joyce et al.
CELL CYCLE (2004)
Activity-based probes for protein tyrosine phosphatases
S Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Comprehensive search for cysteine cathepsins in the human genome
A Rossi et al.
BIOLOGICAL CHEMISTRY (2004)
Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes
XD Huang et al.
DIABETES (2003)
Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter
S Yasothornsrikul et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Relative rates of Michael reactions of 2′-(phenethyl)thiol with vinyl sulfones, vinyl sulfonate esters, and vinyl sulfonamides relevant to vinyl sulfonyl cysteine protease inhibitors
JJ Reddick et al.
ORGANIC LETTERS (2003)
Lysosomal cysteine proteases (cathepsins): promising drug targets
D Turk et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)
Design of noncovalent inhibitors of human cathepsin L.: From the 96-residue proregion to optimized tripeptides
SF Chowdhury et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
J Stypmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
In situ hybridization screen in zebrafish for the selection of genes encoding secreted proteins
PS Crosier et al.
DEVELOPMENTAL DYNAMICS (2001)
Splice variants of human cathepsin L mRNA show different expression rates
A Abudula et al.
BIOLOGICAL CHEMISTRY (2001)
Azepanone-based inhibitors of human and rat cathepsin K
RW Marquis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L
JP Falgueyret et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Development of peptidyl α-keto-β-aldehydes as new inhibitors of cathepsin L -: Comparisons of potency and selectivity profiles with cathepsin B
JF Lynas et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Secreted cathepsin L generates endostatin from collagen XVIII
U Felbor et al.
EMBO JOURNAL (2000)
Distinct roles of cathepsin K and cathepsin L in osteoclastic bone resorption
N Furuyama et al.
ENDOCRINE RESEARCH (2000)
Share Paper
